Significance of Lipoprotein(a) in Coronary Artery Disease ― A Comparative Study of Patients Undergoing Percutaneous Coronary Intervention and Healthy Individuals ―
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Lipoprotein(a) is a risk factor for atherosclerotic cardiovascular disease (ASCVD). However, its distribution based on coronary artery disease (CAD) in the Japanese population remains unclear. We compared lipoprotein(a) distributions among patients with acute coronary syndrome (ACS), patients with chronic coronary syndrome (CCS), and controls. Methods and Results: We analyzed 3,710 individuals who visited Kagawa Prefectural Central Hospital from April 2019 to March 2024. Patients who underwent percutaneous coronary intervention (PCI) were classified into ACS (n=724) and CCS (n=579) groups. Another 2,407 individuals without ASCVD undergoing medical check-ups were the controls. Lipoprotein(a) levels were measured before PCI or during check-up. Distributions and associations with prevalent CAD were assessed using multivariable logistic regression. The mean ages were 70, 72, and 56 years in the ACS, CCS, and control groups, respectively (P
Fields of Study & Subjects
Lipoproteins and Cardiovascular Health
Atherosclerosis and Cardiovascular Diseases
Diabetes
Cardiovascular Risks
and Lipoproteins
Publication details
- Journal / source
- Circulation Reports
- Volume
- 8
- Issue
- 6
- Pages
- 943–951
- Publication date
- 30 March 2026
- Language
- EN